Low-Dose Immunotherapy (LDI) and other Cutting-Edge Therapies (i.e., stem cell, ozone)

Low-dose immunotherapy has been presented by Dr. Hirani at AutismOne 2016 and AutismOne 2017, and it is recommended that the attendee watch the 2016 and 2017 lectures prior to attending/viewing this 2018 presentation. Dr. Hirani will be giving an update on the use of LDI in her practice. It continues to be the most effective biomedical tool she has ever used in treating autism. The Roundup, aluminum and glutamate LDI's are examples of new LDI's Dr. Hirani has been using since last year. Dr. Hirani will also be giving an update on stem cell therapy, which she has been utilizing since 2016. Ozone therapy is a very effective and essentially side-effect free treatment. Although, it has been around since the 1800's, its use in autism has been largely underutilized.


Karima Hirani, MD, MPH

Karima Hirani, MD, is Board Certified in Family Medicine as well as in Integrative and Holistic Medicine (ABIHM) and in Clinical Homeopathy (CEDH). She holds a Masters Degree in Nutrition from UCLA School of Public Health (MPH). She graduated from USC Medical School. She specializes in autism, ADD, and PANDAS since 2001. She practices in Culver City, California. She treats adults as well as children. She is currently taking an international course in ozone therapy from a Spanish Organization, AEPROMO.